STATE STREET CORP - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 59 filers reported holding HOMOLOGY MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q4 2023$81,353
-48.0%
133,8040.0%0.00%
Q3 2023$156,551
+32.2%
133,8040.0%0.00%
Q2 2023$118,417
-14.1%
133,8040.0%0.00%
Q1 2023$137,818
-59.1%
133,804
-50.0%
0.00%
Q4 2022$337,186
+56.8%
267,608
+100.0%
0.00%
Q3 2022$215,000
-19.2%
133,804
-1.0%
0.00%
Q2 2022$266,000
-91.2%
135,134
-86.4%
0.00%
Q1 2022$3,012,000
-2.2%
990,911
+17.1%
0.00%
Q4 2021$3,081,000
-54.4%
846,345
-1.4%
0.00%
Q3 2021$6,752,000
+29.3%
857,995
+19.5%
0.00%
Q2 2021$5,222,000
-18.8%
718,260
+5.1%
0.00%
Q1 2021$6,430,000
-19.1%
683,360
-2.9%
0.00%
Q4 2020$7,950,000
+3.3%
704,120
-2.1%
0.00%
-100.0%
Q3 2020$7,693,000
-65.7%
718,996
-51.3%
0.00%
-50.0%
Q2 2020$22,435,000
+72.8%
1,476,969
+76.8%
0.00%
+100.0%
Q1 2020$12,981,000
-23.5%
835,357
+2.0%
0.00%0.0%
Q4 2019$16,959,000
+10.2%
819,269
-3.6%
0.00%0.0%
Q3 2019$15,386,000
-12.2%
850,047
-5.0%
0.00%0.0%
Q2 2019$17,520,000
+112.7%
895,237
+201.4%
0.00%0.0%
Q1 2019$8,237,000
+34.3%
297,041
+8.3%
0.00%0.0%
Q4 2018$6,132,000
+79.8%
274,222
+83.8%
0.00%
Q3 2018$3,410,000
+21.7%
149,168
+8.6%
0.00%
Q2 2018$2,803,000137,3480.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q2 2023
NameSharesValueWeighting ↓
VV Manager LLC 770,845$17,236,0007.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,227,035$116,877,0004.68%
RTW INVESTMENTS, LP 1,633,491$36,525,0003.40%
Vivo Capital, LLC 1,159,742$25,932,0003.31%
Casdin Capital, LLC 350,000$7,826,0001.34%
Temasek Holdings (Private) Ltd 3,220,293$72,006,0000.50%
Rock Springs Capital Management LP 450,000$10,062,0000.48%
SPHERA FUNDS MANAGEMENT LTD. 161,000$3,600,0000.41%
COURAGE CAPITAL MANAGEMENT LLC 10,000$224,0000.18%
Global Thematic Partners, LLC 134,776$3,014,0000.16%
View complete list of HOMOLOGY MEDICINES INC shareholders